MedPlus Health Services Limited (NSE:MEDPLUS)

Market Cap	103.10B +20.6%
Revenue (ttm)	65.38B +6.9%
Net Income	2.07B +56.4%
EPS	17.24 +56.4%
Shares Out	120.05M
PE Ratio	49.80
Forward PE	43.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100,764
Average Volume	139,253
Open	848.05
Previous Close	854.70
Day's Range	838.85 - 865.65
52-Week Range	678.05 - 1,045.30
Beta	0.51
RSI	55.89
Earnings Date	Jan 30, 2026

About MedPlus Health Services

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing serv...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2006
• Employees: 25,007
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDPLUS

Financial Performance

In fiscal year 2025, MedPlus Health Services's revenue was 61.36 billion, an increase of 9.09% compared to the previous year's 56.25 billion. Earnings were 1.50 billion, an increase of 129.59%.